Related Experiment Video
Updated: Mar 15, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
How Treatment-Refractory Addiction Is Defined: A Scoping Review
Nicholas L Bormann1, Jesse R Burson, Emily M Burson
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN (NLB, JRB, VK, TSO); Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD (EMB); Mayo Clinic Libraries, Mayo Clinic, Rochester, MN (MMG); Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN (BJC); Department of Psychiatry, Washington University in St Louis, St Louis, MO (MG).
Objectives:
The addiction field lacks consensus terminology for individuals who utilize multiple treatments but do not enter remission. This scoping review evaluates how this concept is defined across the literature.
Methods:
A comprehensive search was conducted on September 16, 2024, by a medical librarian. Included articles presented new data in adult substance-using populations described as treatment-resistant or treatment-refractory. Articles were excluded if they lacked a clear definition, if the population assessed was dual diagnosis-focused, or if individuals did not want to engage in care (ie, resisting).
Results:
In total, 1834 and 379 articles were reviewed at the abstract and full-text levels, respectively, with 39 meeting inclusion criteria. Treatment-resistant (n=23) and treatment-refractory (n=11) were the most used terms. Alcohol (n=10) and opioid (n=27) use cohorts were most commonly assessed. Six studies occurred in deep brain stimulation cohorts. Themes of severity of use, treatment history with ongoing use, and psychosocial or functional impairments overlapped definitions; however, they varied widely in specificity. The most comprehensive definitions incorporated thresholds for amount/frequency consumed, duration of addiction or age of onset, number of treatment encounters, treatment duration, and a pharmacological treatment trial.
Conclusions:
The lack of a consistent definition for continued treatment nonresponse poses challenges for research and clinical care. The use of "treatment-refractory" over "treatment-resistant" may better align with person-first language, emphasizing the multifaceted nature of addiction rather than implying something about the individual. An agreed-upon definition may improve the identification of this resource-intensive and at-risk population, guiding the development of tailored interventions that better address their treatment needs.
Related Concept Videos
Treatment Resistent Cancers
Drug Abuse and Addiction: Pharmacological Phenomena
Treatment Resistant Cancers
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications

